Viva Leisure’s IPO: What You Need To Know

Viva Leisure is coming up with the initial public offer or IPO and the price has been fixed at A$1 per share. With the help of this initial public offer or IPO, Viva Leisure would be raising $26 million. If everything goes as per the plans, the company would commence its trading on November 20, 2018 on ASX. The objective of raising capital is to repay its existing debt facilities, pursue growth opportunity, allow shareholders to sell down, and pay for IPO costs. A Stockbroker Ord Minnett has been carrying out the marketing activities for the IPO and it has also engaged itself in calling for the bids. The investors who showed interests have been informed that the fitness industry could be amounting to total $2.5 billion per year by 2023. The company presently is in charge of 30 clubs as well as 42500 members and is a small player carrying out the operations in the gym market.  [optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]

It seems like the fund managers need to work out to execute the deal of Viva Leisure. The fund managers would be comparing the company’s business with the listed ones like Event Hospitality and Entertainment as well as Ardent Leisure. The company’s float comes at a time when there are substantial deals with regard to the health and wellness space. However, Crunch Fitness which is being operated in Australia with the help of husband and wife, as well as Next Gen Health & Lifestyle Clubs (which has been funded by the private equity player), have managed to gain the attraction of the offshore as well as local people.

Notably, Viva Leisure was created so that the assets, as well as the working of The Club Group, are managed. It has been managing 2 health club brands named: Club Lime as well as Club Pink. Additionally, it has been managing a personal training division named as Gymmy PT.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report